Bio-Rad Laboratories, Inc. ( BIO) - Stock Earnings
BIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
BIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 720.0 million USD | 693.2 million USD |
| 2026Q1 | -527.1 million USD | 592.1 million USD |
| 2026Q2 | 371.4 million USD | 651.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -637.3 million USD | 2.7 billion USD |
| 2024 | -1.8 billion USD | 2.6 billion USD |
| 2025 | 759.9 million USD | 2.6 billion USD |
| 2026 Est. | — | — |
BIO
Price: $366.16
Earnings Per Share: 8.26 USD
P/E Ratio: 42.92
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 92800
Ebitda: 79.8 millionMarket Capitalization: 9.9 billion